The FG Loop of PD-1 Serves as a "Hotspot" for Therapeutic Monoclonal Antibodies in Tumor Immune Checkpoint Therapy.
Chen, D., Tan, S., Zhang, H., Wang, H., He, W., Shi, R., Tong, Z., Zhu, J., Cheng, H., Gao, S., Chai, Y., Qi, J., Xiao, M., Yan, J., Gao, G.F.(2019) iScience 14: 113-124
- PubMed: 30952089 
- DOI: 10.1016/j.isci.2019.03.017
- Primary Citation of Related Structures:  
6J14, 6J15 - PubMed Abstract: 
Programmed cell death 1 (PD-1)/PD-1 ligand-1 (PD-L1)-blocking monoclonal antibodies (mAbs) have taken center stage for tumor immune checkpoint therapy. Identification of the "hotspots" on PD-1 for mAbs will help to develop next-generation oral deliverable agents with long-lasting efficacy ...